Correspondence 0001493152-23-033743 from Immix Biopharma, Inc. (IMMX)
Immix Biopharma, Inc.
Date: Sept. 26, 2023 · CIK: 0001873835 · Accession: 0001493152-23-033743
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-274684
Letter
IMMIX BIOPHARMA, INC.
West Olympic Blvd., Suite 200
Los Angeles, CA 90064
VIA EDGAR
September 26, 2023
United States Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, DC 20549
Re: Immix Biopharma, Inc.
Acceleration Request for Registration Statement on Form S-3
Filed September 25, 2023
File No. 333-274684
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Immix Biopharma, Inc. hereby requests that the effective date and time of the above-referenced registration statement be accelerated to September 28, 2023, at 4:05 p.m., Eastern Time, or as soon thereafter as practicable.
If you have any questions regarding this request, please contact Melanie R. Levy of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. at (858) 314 -1873.
Sincerely,
IMMIX
BIOPHARMA, INC.
Show Raw Text
CORRESP
1
filename1.htm
IMMIX
BIOPHARMA, INC.
11400
West Olympic Blvd., Suite 200
Los
Angeles, CA 90064
VIA
EDGAR
September
26, 2023
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
Re:
Immix Biopharma, Inc.
Acceleration
Request for Registration Statement on Form S-3
Filed
September 25, 2023
File
No. 333-274684
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Immix Biopharma, Inc. hereby requests that the effective date and time of the
above-referenced registration statement be accelerated to September 28, 2023, at 4:05 p.m., Eastern Time, or as soon thereafter as practicable.
If
you have any questions regarding this request, please contact Melanie R. Levy of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
at (858) 314 -1873.
Sincerely,
IMMIX
BIOPHARMA, INC.
/s/
Gabriel Morris
Gabriel
Morris
Chief
Financial Officer
cc:
Ilya Rachman, Immix Biopharma, Inc.
Melanie
R. Levy, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.